EP
Eversept Partners Portfolio holdings
AUM
$1.31B
1-Year Est. Return
41.01%
1 Year Est. Return
+41.01%
AUM
$1.31B
AUM Growth
+$313M
(+32%)
Holding
98
Top Buys
| 1 | +$81.3M | |
| 2 | +$51.2M | |
| 3 | +$36.2M | |
| 4 |
Danaher
DHR
|
+$15M |
| 5 |
Insulet
PODD
|
+$14.1M |
Top Sells
| 1 | +$44.5M | |
| 2 | +$21.3M | |
| 3 | +$15.4M | |
| 4 |
Protagonist Therapeutics
PTGX
|
+$15.3M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$13.4M |
Sector Composition
| 1 | Healthcare | 99.96% |
| 2 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NewAmsterdam Pharma
NAMS
$4.03B
| $13.9M | 0.96% |
488,592
+74,162
|
|
||
27
Avidity Biosciences
RNA
$10.8B
| $13.2M | 0.91% |
+302,911
|
|
||
28
Novo Nordisk
NVO
$221B
| $12.1M | 0.83% |
+217,708
|
|
||
29
Illumina
ILMN
$20.7B
| $11.7M | 0.81% |
123,674
-74,910
|
|
||
30
Avantor
AVTR
$7.74B
| $11.5M | 0.8% |
924,442
-601,722
|
|
||
31
Liquidia Corp
LQDA
$2.89B
| $11.1M | 0.76% |
486,021
+127,193
|
|
||
32
MannKind Corp
MNKD
$1.78B
| $11M | 0.76% |
2,042,727
+1,345,017
|
|
||
33
BioCryst Pharmaceuticals
BCRX
$1.63B
| $10.4M | 0.72% |
1,373,625
+165,987
|
|
||
34
ARS Pharmaceuticals
SPRY
$1.04B
| $9.81M | 0.68% |
+976,511
|
|
||
35
Icon
ICLR
$14.3B
| $9.63M | 0.66% |
55,025
-9,562
|
|
||
36
Regeneron Pharmaceuticals
REGN
$76.6B
| $9.4M | 0.65% |
16,720
+3,466
|
|
||
37
Evolus
EOLS
$462M
| $9.06M | 0.62% |
1,475,109
+304,798
|
|
||
38
Edgewise Therapeutics
EWTX
$2.58B
| $8.15M | 0.56% |
502,234
+109,495
|
|
||
39
Centene
CNC
$19.3B
| $8.01M | 0.55% |
224,550
-174,176
|
|
||
40
BioMarin Pharmaceuticals
BMRN
$10.3B
| $7.94M | 0.55% |
+146,642
|
|
||
41
Ardelyx
ARDX
$1.43B
| $7.88M | 0.54% |
+1,429,377
|
|
||
42
Biogen
BIIB
$25.8B
| $7.25M | 0.5% |
+51,765
|
|
||
43
Catalyst Pharmaceutical
CPRX
$2.83B
| $6.91M | 0.48% |
+350,812
|
|
||
44
Dynavax Technologies
DVAX
$1.29B
| $6.89M | 0.47% |
693,527
-503,662
|
|
||
45
Intuitive Surgical
ISRG
$196B
| $6.45M | 0.44% |
+14,426
|
|
||
|
ETNB
46
DELISTED
89bio
ETNB
| $5.77M | 0.4% |
392,441
+156,451
|
|
||
47
HealthEquity
HQY
$8.2B
| $4.96M | 0.34% |
52,388
-103,480
|
|
||
48
Structure Therapeutics
GPCR
$4.29B
| $4.66M | 0.32% |
166,391
+67,053
|
|
||
49
Merus
MRUS
$7.34B
| $4.52M | 0.31% |
48,054
-82,870
|
|
||
50
Alector
ALEC
$144M
| $4.41M | 0.3% |
1,488,725
-497,347
|
|